3-methoxytyramine has been researched along with mazindol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashim, A; Lajtha, A; Sershen, H; Wiener, HL | 1 |
| Bonnet, JJ; Costentin, J; Thibaut, F; Vaugeois, JM | 1 |
2 other study(ies) available for 3-methoxytyramine and mazindol
| Article | Year |
|---|---|
Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corpus Striatum; Dopamine; Male; Mazindol; Mice; Mice, Inbred BALB C; Monoamine Oxidase; Phenethylamines; Receptors, Dopamine; Selegiline | 1989 |
Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice.
Topics: 4-Butyrolactone; Analysis of Variance; Animals; Cerebellum; Cocaine; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; GABA Modulators; Injections, Intravenous; Levodopa; Mazindol; Mice; Neostriatum; Protein Binding; Tritium | 1996 |